Govindarajugari Supritha Bai¹* and Suresh Kishanrao²

¹BPT, (MPH), Karnataka State Rural Development and Panchayat Raj University, India
²Public Health Consultant & Visiting Professor-MPH, India

*Corresponding Author: Govindarajugari Supritha Bai, BPT, (MPH), Karnataka State Rural Development and Panchayat Raj University, India.

Received: July 26, 2021; Published: August 23, 2021

Abstract

  Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, called SARC Covid-19. The first 3 cases of COVID-19 in India were reported in the towns of Thrissur, Alappuzha, and Kasaragod, of Kerala, among Indian medical students who had returned from Wuhan. Lockdown was announced in Kerala on 23^rd March and subsequently in the rest of the country. COVID-19 had a detrimental impact on urban population initially, as the virus has caused hundreds of thousands of deaths. The second phase of COVID-19 since April 2021 has been having devasting effects both in cities and spreading in rural area. Major Indian cities like Mumbai, Delhi, Pune, and Bengaluru, faced a lot of problem as they had run around for hospital beds, drugs, oxygen etc. This was the time every health facility in the cities was roped in the management of cases. I report here a case of a 40 years, railway employee, male diabetic, and obese reporting to a Railway hospital, with the complaints of severe body pain, headache, weakness, sore throat, and breathlessness for 7 days. He tested positive for RT-PCR for corona virus disease. In the first week he had mild symptoms, but in the second week his temperature and breathlessness became severe, compelled him to seek consultation and he was admitted in hospital. Being an employee of the railways, living in the railway quarters is entitled for free treatment, therefore he sought the care there. Railway hospitals provide safe and scientific health services to maximum number of our fellow citizen. He was kept under ventilator and given oxygen, oral medications like Oseltamivir 75 mg twice daily for two days, aziwok 500 mg once a day for five days and HCQS 400 mg twice daily for one day and 200 mg twice a day for four days and for comorbidity of diabetes was given metformin 500 mg twice a day, gluformin 1 mg twice a day, teneligliptin 20 mg once a day (taking in the last 6 months) and with good diet. After 5 days he was weaned off the ventilator and then shifted to general ward and after few days he was discharged and advised for follow-up. At home he followed regular medications, physical activities and followed low carb diet for diabetes and recovered from COVID-19 and is currently normally since 20^th April 2021. He has long term post COVID symptoms like body pains and tiredness even after 6 weeks now.

Keywords: COVID-19; Diabetes; RT-PCR; Obesity; Railway Hospital

References

1. Trivedi L. “Combating COVID-19 pandemic: The role of indian railways”. Apollo Medicine3 (2020): 235-236.
2. Patel CK., et al. “Railway anaesthesiologists and Indian railway COVID-19 management system”. Indian Journal of Anesthesia 64 (2020): S132.
3. Al‐Sabah S., et al. “COVID ‐19: Impact of obesity and diabetes on disease severity”. Clinical Obesity6 (2020).
4. K Suresh. “Impact of COVID-19 Pandemic on Integrated Management of Diabetes in India in 2020”. 3.5 (2021): 24-31.
5. Parasher A. “COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment”. Postgraduate Medical Journal1147 (2021): 312-320.
6. Douedi S and Miskoff J. “Novel coronavirus 2019 (COVID-19)”. Medicine (Baltimore)19 (2020): e20207.
7. Zhao W., et al. “A systematic approach is needed to contain COVID-19 globally”. Science Bulletin11 (2020): 876-878.

Citation

Citation: Govindarajugari Supritha Bai and Suresh Kishanrao. “Railway Hospital Rises to the Occasion: A High Risk Moderately Severe Covid 19 Case Managed". Acta Scientific Women's Health 3.9 (2021): 44-47.

Copyright

Copyright: © 2021 Govindarajugari Supritha Bai and Suresh Kishanrao. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.